Evolus Inc. (EOLS)
Market Closed
26 Oct, 08:00 PM
$
7. 17
+0.16
+2.2825%
$
463.01M Market Cap
- P/E Ratio
- Div Yield
430,106 Volume
-0.57 Eps
$ 7.01
Previous Close 
Want to track EOLS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Evolus (EOLS) Releases Favorable Dermal Fillers Study Data
The addition of Evolysse fillers to the company's portfolio complements Evolus' (EOLS) flagship neurotoxin Jeuveau.
Zacks | 2 years ago
2026 © Marketlog. All Rights Reserved.
